ReviewFrontiers in digital health2026
Explainable AI in kidney stone detection and segmentation: a mini review.
Review in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney stones are one of the most common renal disorders that can produce severe complications if not diagnosed and treated early. Recently, advances in AI have ensured that deep learning and explainable AI enable the automatic segmentation and detection of kidney stones from medical imaging, thus improving diagnostic efficiency and accuracy. For this review, eighteen representative studies using machine learning, deep learning, and hybrid models for kidney stone segmentation were considered, which were published in the period between 2020 and 2025. The XAI techniques being mainly utilized with the discussed models in the study are SHAP, LIME, Grad-CAM, Layer-wise Relevance Propagation, and EigenCAM. Such approaches tend to enhance clinicians' trust in allowing early diagnosis and supporting clinical decision-making, especially in resource-constrained settings. Regardless of the towering results, this area still suffers due to certain limitations such as lack of diversity in datasets, absence of multimodal integration, and scarcity of real-world validation. All in all, integrating DL with XAI presents a transparent, reliable, and clinically acceptable approach to detecting and segmenting kidney stones.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.